GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 18.95
-0.14 (-0.73%)
At close: Sep 10, 2025
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 7.51 billion as of September 11, 2025. Its market cap has increased by 77.30% in one year.
Market Cap
7.51B
Enterprise Value
6.54B
Revenue
721.26M
Ranking
n/a
PE Ratio
72.89
Stock Price
18.95
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has decreased from 7.59B to 7.51B, a decrease of -1.00%. That is a compound annual growth rate of -0.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 7.75B | 47.66% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 473.23B |
| WuXi AppTec | 310.88B |
| Shenzhen Mindray Bio-Medical Electronics | 291.46B |
| Sichuan Biokin Pharmaceutical | 145.24B |
| Shanghai United Imaging Healthcare | 125.96B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.26B |
| Aier Eye Hospital Group | 119.64B |
| Yunnan Baiyao Group Co.,Ltd | 106.68B |